These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 1478716)
1. Pathogenesis of age dependent paralysis by a temperature sensitive mutant (tsl) of Moloney murine leukemia virus-TB. Prasad G; Wong PK Indian J Exp Biol; 1992 Sep; 30(9):814-8. PubMed ID: 1478716 [TBL] [Abstract][Full Text] [Related]
2. Temporal lymphoreticular changes caused by ts1, a paralytogenic mutant of Moloney murine leukemia virus TB. Stoica G; Floyd E; Illanes O; Wong PK Lab Invest; 1992 Apr; 66(4):427-36. PubMed ID: 1583883 [TBL] [Abstract][Full Text] [Related]
3. Rudimentary thymus of SCID mouse plays an important role in the development of retrovirus-induced neurologic disorders. Saha K; Wong PK Virology; 1993 Jul; 195(1):211-8. PubMed ID: 8391182 [TBL] [Abstract][Full Text] [Related]
4. Influence of genotype and the organ of origin on the subtype of T-cell in Moloney lymphomas induced by transfer of preleukemic cells from athymic and thymus-bearing mice. Asjö B; Skoog L; Palminger I; Wiener F; Isaak D; Cerny J; Fenyö EM Cancer Res; 1985 Mar; 45(3):1040-5. PubMed ID: 3871660 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a continuous lymphocyte cell line derived from BALB/c mice inoculated with a recombinant Moloney murine leukemia virus-TB. Prasad G; Wong PK; Yuen PH Indian J Exp Biol; 1992 May; 30(5):357-61. PubMed ID: 1459611 [TBL] [Abstract][Full Text] [Related]
6. Murine leukemia virus induced central nervous system diseases. Wong PK; Shikova E; Lin YC; Saha K; Szurek PF; Stoica G; Madden R; Brooks BR Leukemia; 1992; 6 Suppl 3():161S-165S. PubMed ID: 1602815 [TBL] [Abstract][Full Text] [Related]
7. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia. Nazarov V; Hilbert D; Wolff L Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249 [TBL] [Abstract][Full Text] [Related]
8. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer. Bristol JA; Schlom J; Abrams SI Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883 [TBL] [Abstract][Full Text] [Related]
9. Temporal central and peripheral nervous system changes induced by a paralytogenic mutant of Moloney murine leukemia virus TB. Stoica G; Illanes O; Tasca SI; Wong PK Lab Invest; 1993 Dec; 69(6):724-35. PubMed ID: 8264234 [TBL] [Abstract][Full Text] [Related]
10. The role of the thymus in the pathogenesis of hind-limb paralysis induced by ts1, a mutant of Moloney murine leukemia virus-TB. Prasad G; Stoica G; Wong PK Virology; 1989 Apr; 169(2):332-40. PubMed ID: 2784929 [TBL] [Abstract][Full Text] [Related]
11. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice. Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741 [TBL] [Abstract][Full Text] [Related]
12. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2. Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666 [TBL] [Abstract][Full Text] [Related]
13. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus. Avidan N; Tumas-Brundage KM; Sieck TG; Prystowsky MB; Blank KJ Virology; 1995 Aug; 211(2):507-15. PubMed ID: 7645254 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of murine leukemia. VIII. Efficacy of passive serum therapy of Friend leukemia virus-induced disease in immunocompromised mice. Genovesi EV; Livnat D; Collins JJ J Natl Cancer Inst; 1983 Feb; 70(2):311-22. PubMed ID: 6337292 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms in T cell leukemogenesis. II. T cell responses of preleukemic BALB/c mice to Moloney leukemia virus antigens. Lee JC; Horak I; Ihle JN J Immunol; 1981 Feb; 126(2):715-22. PubMed ID: 6969759 [TBL] [Abstract][Full Text] [Related]
16. Adoptive transfer of murine cytomegalovirus-immune lymph node cells prevents retinitis in T-cell-depleted mice. Lu Y; Bigger JE; Thomas CA; Atherton SS Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):301-10. PubMed ID: 9040462 [TBL] [Abstract][Full Text] [Related]
17. ts1, a temperature-sensitive mutant of Moloney murine leukemia virus TB, can infect both CD4+ and CD8+ T cells but requires CD4+ T cells in order to cause paralysis and immunodeficiency. Saha K; Wong PK J Virol; 1992 May; 66(5):2639-46. PubMed ID: 1348544 [TBL] [Abstract][Full Text] [Related]
18. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes. Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898 [TBL] [Abstract][Full Text] [Related]
19. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments. Weiss L; Reich S; Slavin S Cytokines Cell Mol Ther; 1999 Sep; 5(3):145-52. PubMed ID: 10641572 [TBL] [Abstract][Full Text] [Related]
20. High susceptibility of FVB/N mice to the paralytic disease induced by ts1, a mutant of Moloney murine leukemia virus TB. Wong PK; Floyd E; Szurek PF Virology; 1991 Jan; 180(1):365-71. PubMed ID: 1984656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]